Report New Zealand - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights for 499$
Latest Report Update: Jun 26, 2022

New Zealand - Medicaments Containing Insulin But not Antibiotics in Measured Doses - Market Analysis, Forecast, Size, Trends and Insights
Update: COVID-19 Impact

Pricing Plan

You will receive a PDF copy of the report by email within 24 hours (Mon - Fri).

By clicking «Buy the Report», you agree to our Terms of Service, Privacy Policy and Licenses. We'll occasionally send you account related emails.

New Zealand: Market for Medicaments Containing Insulin But Not Antibiotics In Measured Doses 2022

Market Size for Medicaments Containing Insulin But Not Antibiotics In Measured Doses in New Zealand

The New Zealand prophylactic medicaments containing insulin market skyrocketed to $X in 2021, growing by X% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). The market value increased at an average annual rate of +X% over the period from 2012 to 2021; the trend pattern indicated some noticeable fluctuations being recorded in certain years. Prophylactic medicaments containing insulin consumption peaked in 2021 and is expected to retain growth in years to come.

Exports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Exports from New Zealand

In 2021, approx. X kg of medicaments containing insulin but not antibiotics in measured doses were exported from New Zealand; shrinking by -X% on 2020 figures. Overall, exports, however, recorded a strong expansion. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. The exports peaked at X tons in 2014; however, from 2015 to 2021, the exports remained at a lower figure.

In value terms, prophylactic medicaments containing insulin exports declined dramatically to $X in 2021. In general, exports, however, continue to indicate a significant increase. The most prominent rate of growth was recorded in 2013 with an increase of X% against the previous year. Over the period under review, the exports reached the maximum at $X in 2020, and then shrank notably in the following year.

Exports by Country

Fiji (X kg) was the main destination for prophylactic medicaments containing insulin exports from New Zealand, accounting for a X% share of total exports. Moreover, prophylactic medicaments containing insulin exports to Fiji exceeded the volume sent to the second major destination, Niue (X kg), more than tenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume to Fiji amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Niue (+X% per year) and Cook Islands (+X% per year).

In value terms, Fiji ($X) remains the key foreign market for prophylactic medicaments containing insulin exports from New Zealand, comprising X% of total exports. The second position in the ranking was occupied by Niue ($X), with a X% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to Fiji amounted to +X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Niue (+X% per year) and Cook Islands (+X% per year).

Export Prices by Country

The average prophylactic medicaments containing insulin export price stood at $X per ton in 2021, increasing by X% against the previous year. Overall, the export price saw strong growth. The pace of growth was the most pronounced in 2016 an increase of X%. The export price peaked at $X per ton in 2019; however, from 2020 to 2021, the export prices failed to regain momentum.

Average prices varied noticeably for the major export markets. In 2021, the country with the highest price was Cook Islands ($X per ton), while the average price for exports to Fiji ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Fiji (+X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Medicaments Containing Insulin But Not Antibiotics In Measured Doses

Imports into New Zealand

In 2021, approx. X tons of medicaments containing insulin but not antibiotics in measured doses were imported into New Zealand; surging by X% on the previous year. The total import volume increased at an average annual rate of +X% over the period from 2012 to 2021; the trend pattern remained relatively stable, with only minor fluctuations throughout the analyzed period. The most prominent rate of growth was recorded in 2014 when imports increased by X% against the previous year. As a result, imports reached the peak of X tons. From 2015 to 2021, the growth imports failed to regain momentum.

In value terms, prophylactic medicaments containing insulin imports surged to $X in 2021. In general, total imports indicated buoyant growth from 2012 to 2021: its value increased at an average annual rate of +X% over the last nine-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. The pace of growth was the most pronounced in 2013 with an increase of X%. Over the period under review, imports reached the peak figure in 2021 and are likely to see gradual growth in years to come.

Imports by Country

Brazil (X tons), Australia (X tons) and Italy (X tons) were the main suppliers of prophylactic medicaments containing insulin imports to New Zealand, with a combined X% share of total imports.

From 2012 to 2021, the biggest increases were in Brazil (with a CAGR of +X%), while purchases for the other leaders experienced more modest paces of growth.

In value terms, Brazil ($X), Australia ($X) and Italy ($X) were the largest prophylactic medicaments containing insulin suppliers to New Zealand, together comprising X% of total imports.

Australia, with a CAGR of +X%, saw the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

In 2021, the average prophylactic medicaments containing insulin import price amounted to $X per ton, surging by X% against the previous year. Over the last nine years, it increased at an average annual rate of +X%. The pace of growth was the most pronounced in 2015 when the average import price increased by X% against the previous year. Over the period under review, average import prices hit record highs at $X per ton in 2018; however, from 2019 to 2021, import prices remained at a lower figure.

There were significant differences in the average prices amongst the major supplying countries. In 2021, the country with the highest price was France ($X per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Australia (+X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Base Year Historical Period Forecast Period Units
2021 2007-2021 2022-2030 US$, Tons

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of in 2021 were China, the United States and India, together comprising 52% of global consumption.
What are the largest producers of medicaments containing insulin but not antibiotics in measured doses in the world?
+
The countries with the highest volumes of in 2021 were China, the United States and India, with a combined 52% share of global production.
What are the leading suppliers of medicaments containing insulin but not antibiotics in measured doses to New Zealand?
+
In value terms, the largest prophylactic medicaments containing insulin suppliers to New Zealand were Brazil, Australia and Italy, together comprising 81% of total imports.
What are the leading importers of medicaments containing insulin but not antibiotics in measured doses from New Zealand?
+
In value terms, Fiji remains the key foreign market for prophylactic medicaments containing insulin exports from New Zealand, comprising 90% of total exports. The second position in the ranking was occupied by Niue, with a 5.4% share of total exports.
What is the average export price for medicaments containing insulin but not antibiotics in measured doses in New Zealand?
+
In 2021, the average prophylactic medicaments containing insulin export price amounted to $326,610 per ton, surging by 9.6% against the previous year.
What is the average import price for medicaments containing insulin but not antibiotics in measured doses in New Zealand?
+
In 2021, the average prophylactic medicaments containing insulin import price amounted to $259,798 per ton, picking up by 11% against the previous year.

This report provides an in-depth analysis of the market for prophylactic medicaments containing insulin in New Zealand. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.


Product coverage:
• Prodcom 21201260 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, put up in measured doses or for retail sale
Country coverage:
• New Zealand

Data coverage:
• Market volume and value
• Per Capita consumption
• Forecast of the market dynamics in the medium term
• Trade (exports and imports) in New Zealand
• Export and import prices
• Market trends, drivers and restraints
• Key market players and their profiles

Reasons to buy this report:
• Take advantage of the latest data
• Find deeper insights into current market developments
• Discover vital success factors affecting the market
This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:
1. How to diversify your business and benefit from new market opportunities
2. How to load your idle production capacity
3. How to boost your sales on overseas markets
4. How to increase your profit margins
5. How to make your supply chain more sustainable
6. How to reduce your production and supply chain costs
7. How to outsource production to other countries
8. How to prepare your business for global expansion
While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.
1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business

1.1
REPORT DESCRIPTION
1.2
RESEARCH METHODOLOGY AND AI PLATFORM
1.3
DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
1.4
GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance

3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects

3.1
MARKET SIZE
3.2
MARKET STRUCTURE
3.3
TRADE BALANCE
3.4
PER CAPITA CONSUMPTION
3.5
MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCTS

Finding New Products to Diversify Your Business

4.1
TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
4.2
BEST-SELLING PRODUCTS
4.3
MOST CONSUMED PRODUCT
4.4
MOST TRADED PRODUCT
4.5
MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain

5.1
TOP COUNTRIES TO SOURCE YOUR PRODUCT
5.2
TOP PRODUCING COUNTRIES
5.3
TOP EXPORTING COUNTRIES
5.4
LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports

6.1
TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
6.2
TOP CONSUMING MARKETS
6.3
UNSATURATED MARKETS
6.4
TOP IMPORTING MARKETS
6.5
MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry

7.1
PRODUCTION VOLUME AND VALUE
8. IMPORTS

The Largest Import Supplying Countries

8.1
IMPORTS FROM 2012–2021
8.2
IMPORTS BY COUNTRY
8.3
IMPORT PRICES BY COUNTRY
9. EXPORTS

The Largest Destinations for Exports

9.1
EXPORTS FROM 2012–2021
9.2
EXPORTS BY COUNTRY
9.3
EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles

LIST OF TABLES
Table 1:
Key Findings In 2021
Table 2:
Market Volume, In Physical Terms, 2012–2021
Table 3:
Market Value, 2012–2021
Table 4:
Per Capita Consumption In 2012–2021
Table 5:
Imports, In Physical Terms, By Country, 2012–2021
Table 6:
Imports, In Value Terms, By Country, 2012–2021
Table 7:
Import Prices, By Country Of Origin, 2012–2021
Table 8:
Exports, In Physical Terms, By Country, 2012–2021
Table 9:
Exports, In Value Terms, By Country, 2012–2021
Table 10:
Export Prices, By Country Of Destination, 2012–2021
LIST OF FIGURES
Figure 1:
Market Volume, In Physical Terms, 2012–2021
Figure 2:
Market Value, 2012–2021
Figure 3:
Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012–2021
Figure 4:
Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012–2021
Figure 5:
Trade Balance, In Physical Terms, 2012–2021
Figure 6:
Trade Balance, In Value Terms, 2012–2021
Figure 7:
Per Capita Consumption, 2012–2021
Figure 8:
Market Forecast To 2030
Figure 9:
Products: Market Size And Growth, By Type
Figure 10:
Products: Average Per Capita Consumption, By Type
Figure 11:
Products: Exports And Growth, By Type
Figure 12:
Products: Export Prices And Growth, By Type
Figure 13:
Production Volume And Growth
Figure 14:
Exports And Growth
Figure 15:
Export Prices And Growth
Figure 16:
Market Size And Growth
Figure 17:
Per Capita Consumption
Figure 18:
Imports And Growth
Figure 19:
Import Prices
Figure 20:
Production, In Physical Terms, 2012–2021
Figure 21:
Production, In Value Terms, 2012–2021
Figure 22:
Imports, In Physical Terms, 2012–2021
Figure 23:
Imports, In Value Terms, 2012–2021
Figure 24:
Imports, In Physical Terms, By Country, 2021
Figure 25:
Imports, In Physical Terms, By Country, 2012–2021
Figure 26:
Imports, In Value Terms, By Country, 2012–2021
Figure 27:
Import Prices, By Country Of Origin, 2012–2021
Figure 28:
Exports, In Physical Terms, 2012–2021
Figure 29:
Exports, In Value Terms, 2012–2021
Figure 30:
Exports, In Physical Terms, By Country, 2021
Figure 31:
Exports, In Physical Terms, By Country, 2012–2021
Figure 32:
Exports, In Value Terms, By Country, 2012–2021
Figure 33:
Export Prices, By Country Of Destination, 2012–2021
Webinar: Decarbonisation and Your Business Strategy - Zero Net Carbon Buildings

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 22nd, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Tools and Marketplaces

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, February 8th, 2022 @ 04:00 pm ET

Webinar: Decarbonisation and Your Business Strategy - Steps and Practices

Join us in our latest webinar series to get insights from industry experts and engage in a productive discussion!



Tuesday, January 25th, 2022 @ 04:00 pm ET